Artículo
The efficacy and safety of granulocyte colony-stimulating factor in the treatment of acute-on-chronic liver failure: A systematic review and meta-analysis
Autor/es | Qiu, B.
Liang, J.X. Romero Gómez, Manuel |
Departamento | Universidad de Sevilla. Departamento de Medicina |
Fecha de publicación | 2023-11-30 |
Fecha de depósito | 2024-03-11 |
Publicado en |
|
Resumen | Background and objectives
The safety and efficacy of granulocyte-colony stimulating factor (G-CSF) for the treatment
of acute-on-chronic liver failure (ACLF) remain controversial. This meta-analysis aimed to
evaluate ... Background and objectives The safety and efficacy of granulocyte-colony stimulating factor (G-CSF) for the treatment of acute-on-chronic liver failure (ACLF) remain controversial. This meta-analysis aimed to evaluate the effectiveness and safety of G-CSF in treating ACLF. Methods The estimated pooled risk ratio (RR) and 95% confidence interval (CI) assessed the treatment effects of G-CSF. Mean differences (MD) and 95% confidence intervals were used to analyze continuous data. Heterogeneity was explored by sensitivity analysis. Potential publication bias was assessed using Egger’s test. Results Ten studies, comprising a total of 603 participants, were included in the analysis. The GCSF group showed significantly lower MELD scores at 7-day (MD = -2.39, 95%CI: -3.95 to -0.82), CTP scores at 7-day (MD = -0.77, 95%CI: -1.41 to -0.14), and MELD scores at 30- day (MD = -3.01, 95%CI: -5.36 to -0.67) compared to the control group. Furthermore, the GCSF group was associated with a reduced risk of sepsis (RR = 0.53, 95%CI: 0.35–0.80). The 30-day survival (RR = 1.26, 95%CI:1.10–1.43), 60-day survival (RR = 1.47, 95% CI:1.17–1.84, and 90-day survival (RR = 1.73, 95%CI: 1.27–2.35) of patients with ACLF treated with G-CSF were significantly higher than those of the control group. Conclusions Our meta-analysis suggests that G-CSF therapy may be a promising treatment for ACLF, with significant improvements in liver function and survival rates, however, further studies are needed to verify this conclusion. |
Cita | Qiu, B., Liang, J.X. y Romero Gómez, M. (2023). The efficacy and safety of granulocyte colony-stimulating factor in the treatment of acute-on-chronic liver failure: A systematic review and meta-analysis. Plos One, 18 (11), e0294818. https://doi.org/10.1371/journal.pone.0294818. |
Ficheros | Tamaño | Formato | Ver | Descripción |
---|---|---|---|---|
The efficacy...pdf | 2.482Mb | [PDF] | Ver/ | |